These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Leifheit-Nestler M, Große Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D. Nephrol Dial Transplant; 2016 Jul 18; 31(7):1088-99. PubMed ID: 26681731 [Abstract] [Full Text] [Related]
6. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome. Hao H, Ma S, Zheng C, Wang Q, Lin H, Chen Z, Xie J, Chen L, Chen K, Wang Y, Huang X, Cao S, Liao W, Bin J, Liao Y. Aging (Albany NY); 2021 Jan 15; 13(2):2982-3009. PubMed ID: 33460402 [Abstract] [Full Text] [Related]
12. FGF23 promotes myocardial fibrosis in mice through activation of β-catenin. Hao H, Li X, Li Q, Lin H, Chen Z, Xie J, Xuan W, Liao W, Bin J, Huang X, Kitakaze M, Liao Y. Oncotarget; 2016 Oct 04; 7(40):64649-64664. PubMed ID: 27579618 [Abstract] [Full Text] [Related]
13. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition. de Seigneux S, Martin PY. Pharmacol Res; 2016 Apr 04; 106():87-91. PubMed ID: 26900884 [Abstract] [Full Text] [Related]
14. Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23. Leifheit-Nestler M, Richter B, Basaran M, Nespor J, Vogt I, Alesutan I, Voelkl J, Lang F, Heineke J, Krick S, Haffner D. Front Endocrinol (Lausanne); 2018 Apr 04; 9():333. PubMed ID: 29977226 [Abstract] [Full Text] [Related]
15. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis. Barnes JW, Duncan D, Helton S, Hutcheson S, Kurundkar D, Logsdon NJ, Locy M, Garth J, Denson R, Farver C, Vo HT, King G, Kentrup D, Faul C, Kulkarni T, De Andrade JA, Yu Z, Matalon S, Thannickal VJ, Krick S. Am J Physiol Lung Cell Mol Physiol; 2019 Jul 01; 317(1):L141-L154. PubMed ID: 31042083 [Abstract] [Full Text] [Related]
17. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. Leifheit-Nestler M, Grabner A, Hermann L, Richter B, Schmitz K, Fischer DC, Yanucil C, Faul C, Haffner D. Nephrol Dial Transplant; 2017 Sep 01; 32(9):1493-1503. PubMed ID: 28339837 [Abstract] [Full Text] [Related]
18. Direct and indirect effects of fibroblast growth factor 23 on the heart. Nakano T, Kishimoto H, Tokumoto M. Front Endocrinol (Lausanne); 2023 Sep 01; 14():1059179. PubMed ID: 36909314 [Abstract] [Full Text] [Related]